论文部分内容阅读
目的分析红霉素静脉滴注结合布地奈德混悬液雾化吸入治疗儿童支原体肺炎的效果。方法选取2010年1月~2013年3月在本院收治的肺炎支原体肺炎患儿83例,将其分为治疗组44例、对照组39例。治疗组采用红霉素静脉滴注结合布地奈德混悬液雾化吸入治疗,对照组仅采用红霉素静脉滴注治疗,比较两组的疗效、临床症状和体征消失的时间。结果治疗组:痊愈31例,有效12例,无效1例,治愈率为70.4%;对照组:痊愈20例,有效17例,无效2例,治愈率为51.3%,治疗组的治愈率明显高于对照组(P<0.05);治疗组的临床症状(发热、咳嗽)、肺部喘息体征消失的时间分别为(5.9±1.6)、(6.5±2.1)d明显短于对照组的(6.8±1.9)、(7.9±2.5)d(P<0.05)。结论红霉素静脉滴注结合布地奈德混悬液雾化吸入治疗儿童支原体肺炎的效果较好,且能明显缩短疗程。
Objective To analyze the effect of erythromycin intravenous drip combined with budesonide suspension atomization inhalation in children with mycoplasma pneumonia. Methods 83 children with Mycoplasma pneumoniae pneumonia admitted in our hospital from January 2010 to March 2013 were divided into treatment group (n = 44) and control group (n = 39). The treatment group was treated with erythromycin intravenous infusion combined with budesonide suspension atomization inhalation treatment, the control group only treated with erythromycin intravenous infusion, the curative effect, clinical symptoms and signs of the disappearance of the two groups were compared. Results In the treatment group, 31 cases were cured, 12 cases were effective and 1 case was ineffective. The cure rate was 70.4%. In the control group, 20 cases were cured, 17 cases were effective and 2 cases were ineffective. The cure rate was 51.3%. The cure rate of the treatment group was significantly higher (5.9 ± 1.6) and (6.5 ± 2.1) d in the treatment group were significantly shorter than those in the control group (6.8 ± 1.9), (7.9 ± 2.5) d (P <0.05). Conclusion Erythromycin intravenous infusion of budesonide suspension atomization inhalation treatment of children with mycoplasma pneumonia is better, and can significantly shorten the course of treatment.